Cabergoline is frequently being requested by many postpartum women with a live newborn to suppress lactation. The aim of the study is to investigate which women desire such an intervention, and what side effects they are experiencing.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Demographics of women requesting cabergoline
Timeframe: immediate postpartum
Number of participants experiencing immediate treatment-related adverse events
Timeframe: immediate postpartum
Number of participants experiencing early treatment-related adverse events
Timeframe: 1 week postpartum
Number of participants experiencing late treatment-related adverse events
Timeframe: six weeks postpartum